3,3-diphenyl-1-(4-(piperidin-4-ylmethyl)piperazin-1-yl)propan-1-one

ID: ALA599425

PubChem CID: 46233646

Max Phase: Preclinical

Molecular Formula: C25H33N3O

Molecular Weight: 391.56

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(CC(c1ccccc1)c1ccccc1)N1CCN(CC2CCNCC2)CC1

Standard InChI:  InChI=1S/C25H33N3O/c29-25(28-17-15-27(16-18-28)20-21-11-13-26-14-12-21)19-24(22-7-3-1-4-8-22)23-9-5-2-6-10-23/h1-10,21,24,26H,11-20H2

Standard InChI Key:  SMXYGIYCXXQYLV-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
    1.5168   -1.2893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5168   -2.1143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8023   -2.5268    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0879   -2.1143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0879   -1.2893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8023   -0.8768    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8023   -3.3518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8023   -0.0518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0879    0.3607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0879    1.1857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6266    1.5982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8023    1.5982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6266    2.4232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3411    2.8357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0555    2.4232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0555    1.5982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3411    1.1857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8023    2.4232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5168    2.8357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2313    2.4232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2313    1.5982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5168    1.1857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5168    0.3607    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0879   -3.7643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0879   -4.5893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6266   -5.0018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3411   -4.5893    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3411   -3.7643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6266   -3.3518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  3  7  1  0
 14 15  2  0
  1  2  1  0
 15 16  1  0
  6  8  1  0
 16 17  2  0
 17 11  1  0
  1  6  1  0
 12 18  2  0
  8  9  1  0
 18 19  1  0
  2  3  1  0
 19 20  2  0
  9 10  1  0
 20 21  1  0
  3  4  1  0
 21 22  2  0
 22 12  1  0
 10 11  1  0
  8 23  2  0
 24 25  1  0
  4  5  1  0
 10 12  1  0
  5  6  1  0
 11 13  2  0
 13 14  1  0
 24 29  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
  7 24  1  0
M  END

Associated Targets(Human)

CACNA2D1 Tclin N-type calcium channel alpha-1b/alpha2delta-1/beta-1b (50 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CACNA2D1 Tclin Voltage-dependent L-type calcium channel alpha1C/alpha2delta/beta1b (64 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 391.56Molecular Weight (Monoisotopic): 391.2624AlogP: 3.35#Rotatable Bonds: 6
Polar Surface Area: 35.58Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.35CX LogP: 3.07CX LogD: -0.54
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.82Np Likeness Score: -0.82

References

1. Pajouhesh H, Feng ZP, Ding Y, Zhang L, Pajouhesh H, Morrison JL, Belardetti F, Tringham E, Simonson E, Vanderah TW, Porreca F, Zamponi GW, Mitscher LA, Snutch TP..  (2010)  Structure-activity relationships of diphenylpiperazine N-type calcium channel inhibitors.,  20  (4): [PMID:20117000] [10.1016/j.bmcl.2010.01.008]

Source